Role of Concomitant Chemoradiation in Locally Advanced Head and Neck Cancers |
Lasrado, Savita
(Department of Otorhinolaryngology and Head and Neck Surgery, Father Muller Medical College)
Moras, Kuldeep (Department of Otorhinolaryngology and Head and Neck Surgery, Father Muller Medical College) Pinto, George Jawahar Oliver (Department of Otorhinolaryngology and Head and Neck Surgery, Father Muller Medical College) Bhat, Mahesh (Department of Otorhinolaryngology and Head and Neck Surgery, Father Muller Medical College) Hegde, Sanath (Indian Institute of Oncology) Sathian, Brijesh (Department of Community Medicine, Manipal College of Medical Sciences) Luis, Neil Aaron (Dental Surgeon in Private Practice) |
1 | Herman LC, Chen L, Garnett A, et al (2014). Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer. Oral Oncol, 50, 52-8. DOI |
2 | Al-Sarraf M (1988). Head and neck cancer: chemotherapy concepts. Semin Oncol, 15, 70-85. |
3 | Baykara M, Buyukberber S, Ozturk B, et al (2013). Efficacy and safety of concomitant chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced squamous cell head and neck cancers. Asian Pac J Cancer Prev, 14, 2557-61. 과학기술학회마을 DOI ScienceOn |
4 | Takiar R, Nadayil d, Nandakumar A (2010). Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev, 11, 1045-9. |
5 | Vokes EE, Weichselbaum RR, Lippman SM, Hong WK (1993). Head and neck cancer. N Engl J Med, 328, 184-94. DOI ScienceOn |
6 | Yang LX, Douple E, Wang HJ (1995). Irradiation- enhanced binding of carboplatin to DNA. Int J Radiat Biol, 68, 609-614. DOI |
7 | Zhu WG, Zhou K, Yu CH, et al (2012). Efficacy analysis of simplified intensity-modulated radiotherapy with high or conventional dose and concurrent chemotherapy for patients with neck and upper thoracic esophageal carcinoma.. Asian Pac J Cancer Prev, 13, 803-7. 과학기술학회마을 DOI ScienceOn |
8 | Nguyen NP, Vos P, Smith HJ, et al (2007). Concurrent chemoradiation for locally advanced oropharyngeal cancer. Am J Otolaryngol, 28, 3-8. DOI |
9 | Hosokawa Y, Kamada T, Shirato H, et al (1995). Simultaneous carboplatin and radiotherapy for all stages of head and neck squamous cell carcinoma. Clin Oncol, 7, 168-72. DOI |
10 | Nam EJ, Lee M, Yim GA, et al (2013). Comparison of carboplatinand cisplatin-based concurrent chemoradiotherapy in locally advanced cervical cancer patients with morbidity risks. Oncologist, 18, 843-9. DOI |
11 | Okami K, Hamano T, Takeo T, Sugimoto R, Sekine M (2007). A survey of head and neck malignancy at Tokai University Hospital. Tokai J Exp Clin Med, 32, 62-6. |
12 | Pignon JP, Bourhis J, Domenge C, Designe L (2000). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta. analyses of updated individual data. Lancet, 355, 949-55. DOI ScienceOn |
13 | Taguchi T, Tsukuda M, Mikami Y, et al (2009). Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Auris Nasus Larynx, 36, 199-204. DOI |
14 | Robert JK, Benjamin GW, Cleveland OH, et al (1988). Squamous cell carcinoma of head and neck in patients 40 years of age and younger. Laryngocsope, 531-3. |
15 | Seiwert TY, Salama JK, Vokes EE (2007). The concurrent chemoradiation paradigm-general principles. Nat Clin Pract Oncol, 4, 86-100. DOI ScienceOn |
16 | Shah JP, Ladd W (1995). Treatment of cancer of the head and neck. CA Cancer J Clin, 45, 352-68. DOI ScienceOn |
17 | Denis F, Garaud P, Bardet E, et al (2004). Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced stage oropharynx carcinoma. J Clin Oncol, 22, 69-76. |
18 | Bertino G, Occhini A, Falco CE, et al (2009).Concurrent intraarterial carboplatin administration and radiation therapy for treatment of advanced head and neck squamous cell carcinoma: short term results. BMC Cancer, 9, 313. DOI |
19 | Calcattera TC, Juillard GJ (1995). Oral cavity and hypopharynxhead and neck cancer. In: Haskell CM, Berek JS, editors. Cancer Treatment. WB Saunders Co:Philadelphia, .p.726-732. |
20 | Dinshaw KA, Rao DN, Ganesh B (2000). Hospital based cancer registry, annual report, Tata Memorial Hospital, Mumbai, India. |
21 | Eisenberger M, Sinibaldi V, Jacobs M, Gray W (1988). Simultaneous treatment with carboplatin (NSC-241-240) and radiotherapy in advanced unresectable squamous cell carcinomas of the head and neck. Cancer Treat Rev, 1988, 3-7. |
22 | Haddad R, O'Neill A, Rabinowits G, et al (2013). Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. Lancet Oncol, 14, 257-64. DOI ScienceOn |
23 | Mabanta SR, Mendenhall WM, Stringer SP, Cassisi NJ (1999). Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinomawith clinically positive neck nodes. Head Neck, 21, 591-4 DOI |
24 | Calais G, Alfonsi M, Bardet E, et al (1999). Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J Natl Cancer Inst, 91, 2081-6. DOI ScienceOn |